Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Acasti Pharma (ACST)

Acasti Pharma (ACST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,764
  • Shares Outstanding, K 26,050
  • Annual Sales, $ 200 K
  • Annual Income, $ -19,680 K
  • 60-Month Beta 1.99
  • Price/Sales 229.93
  • Price/Cash Flow N/A
  • Price/Book 0.84
Trade ACST with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6600 +1.81%
on 10/25/21
2.3800 -28.99%
on 09/27/21
-0.5700 (-25.22%)
since 09/24/21
3-Month
1.6600 +1.81%
on 10/25/21
4.5120 -62.54%
on 08/04/21
-2.1244 (-55.69%)
since 07/23/21
52-Week
1.3680 +23.54%
on 11/06/20
9.7600 -82.68%
on 02/10/21
+0.0340 (+2.05%)
since 10/23/20

Most Recent Stories

More News
Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan

Patents strengthen Acasti’s IP portfolio and provide protection through 2036 and 2037, respectively...

ACST.VN : 2.100 (unch)
ACST : 1.6900 (+0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R)...

See More

Key Turning Points

3rd Resistance Point 1.7800
2nd Resistance Point 1.7500
1st Resistance Point 1.7200
Last Price 1.6900
1st Support Level 1.6600
2nd Support Level 1.6300
3rd Support Level 1.6000

See More

52-Week High 9.7600
Fibonacci 61.8% 6.5543
Fibonacci 50% 5.5640
Fibonacci 38.2% 4.5737
Last Price 1.6900
52-Week Low 1.3680

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar